Serum HER-2/neuand relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer-Reference-Cited by-同舟云学术

Serum HER-2/neuand relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer

Published:2008-09-15 Issue:6 Volume:113 Page:1294-1301
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ali Suhail M.,Carney Walter P.,Esteva Francisco J.,Fornier Monica,Harris Lyndsay,Köstler Wolfgang. J.,Lotz Jean-Pierre,Luftner Diana,Pichon Marie-France,Lipton Allan,

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science.,1987

3. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: direct comparison of fluorescence in situ hybridization and immunohistochemistry;Pauletti;J Clin Oncol.,2000

4. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science.,1989

5. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in nonsmall cell lung cancer;Zhou;Cancer Cell.,2006

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab;International Journal of Clinical Oncology;2024-04-08

2. Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients;Breast Cancer: Targets and Therapy;2024-04

3. Exploratory Analysis of Serum HER2 Extracellular Domain for HER2 Positive Gastric Cancer Treated with SOX plus Trastuzumab;2023-11-29

4. Towards a platform quantitative systems pharmacology (QSP) model for preclinical to clinical translation of antibody drug conjugates (ADCs);Journal of Pharmacokinetics and Pharmacodynamics;2023-10-03

5. Inhibition of DPAGT1 suppresses HER2 shedding and trastuzumab resistance in human breast cancer;Journal of Clinical Investigation;2023-07-17